Abbreviated MRI for HCC surveillance: is it ready for clinical use?

Naik Vietti Violi; Bachir Taouli

doi:10.1007/s00330-020-06904-8

Abbreviated MRI for HCC surveillance: is it ready for clinical use?

Eur Radiol. 2020 Aug;30(8):4147-4149. doi: 10.1007/s00330-020-06904-8. Epub 2020 May 12.

Authors

Naik Vietti Violi¹, Bachir Taouli^{2

3}

Affiliations

¹ Department of Radiology, Lausanne University Hospital, Lausanne, Switzerland.
² Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. bachir.taouli@mountsinai.org.
³ BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Avenue, New York, NY, 10029, USA. bachir.taouli@mountsinai.org.

PMID: 32394280
DOI: 10.1007/s00330-020-06904-8

Abstract

• Abbreviated MRI (AMRI) protocols consist of acquiring only a minimal number of MRI sequences for HCC surveillance with acceptable diagnostic performance compared to complete MRI.• AMRI protocol options include non-contrast AMRI, dynamic AMRI or hepatobiliary phase AMRI post gadoxetate injection.• The best AMRI protocol for HCC surveillance needs to be defined in a large multicentre prospective study.

Publication types

Editorial

MeSH terms

Carcinoma, Hepatocellular / diagnostic imaging*
Contrast Media
Gadolinium DTPA
Humans
Liver Neoplasms / diagnostic imaging*
Magnetic Resonance Imaging / methods*

Substances

Contrast Media
gadolinium ethoxybenzyl DTPA
Gadolinium DTPA